Found: 3
Select item for more details and to access through your institution.
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIVInfected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 1, p. 18, doi. 10.1093/infdis/jiu631
- By:
- Publication type:
- Article
Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 3, p. 390, doi. 10.1093/cid/ciab990
- By:
- Publication type:
- Article
Immunogenicity, Safety, and Tolerability of 13-Valent Pneumococcal Conjugate Vaccine Followed by 23-Valent Pneumococcal Polysaccharide Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Aged =2 Years: An Open-Label Study.
- Published in:
- Clinical Infectious Diseases, 2015, v. 61, n. 3, p. 313, doi. 10.1093/cid/civ287
- By:
- Publication type:
- Article